NL189281C - Werkwijze voor het bereiden van eiwitmateriaal met hormonale activiteit uit de thymus, en preparaat dat dergelijk eiwitmateriaal bevat. - Google Patents

Werkwijze voor het bereiden van eiwitmateriaal met hormonale activiteit uit de thymus, en preparaat dat dergelijk eiwitmateriaal bevat.

Info

Publication number
NL189281C
NL189281C NLAANVRAGE7801422,A NL7801422A NL189281C NL 189281 C NL189281 C NL 189281C NL 7801422 A NL7801422 A NL 7801422A NL 189281 C NL189281 C NL 189281C
Authority
NL
Netherlands
Prior art keywords
protein material
preparation containing
thymus
thymosin fraction
reconstitution
Prior art date
Application number
NLAANVRAGE7801422,A
Other languages
English (en)
Other versions
NL189281B (nl
NL7801422A (nl
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NL7801422A publication Critical patent/NL7801422A/nl
Publication of NL189281B publication Critical patent/NL189281B/nl
Application granted granted Critical
Publication of NL189281C publication Critical patent/NL189281C/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2292—Thymosin; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
NLAANVRAGE7801422,A 1977-02-22 1978-02-07 Werkwijze voor het bereiden van eiwitmateriaal met hormonale activiteit uit de thymus, en preparaat dat dergelijk eiwitmateriaal bevat. NL189281C (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/770,480 US4082737A (en) 1977-02-22 1977-02-22 Stabilized thymosin composition and method

Publications (3)

Publication Number Publication Date
NL7801422A NL7801422A (nl) 1978-08-24
NL189281B NL189281B (nl) 1992-10-01
NL189281C true NL189281C (nl) 1993-03-01

Family

ID=25088687

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7801422,A NL189281C (nl) 1977-02-22 1978-02-07 Werkwijze voor het bereiden van eiwitmateriaal met hormonale activiteit uit de thymus, en preparaat dat dergelijk eiwitmateriaal bevat.

Country Status (20)

Country Link
US (1) US4082737A (nl)
JP (1) JPS53104719A (nl)
AT (1) AT363177B (nl)
AU (1) AU516946B2 (nl)
BE (1) BE864139A (nl)
CA (1) CA1099633A (nl)
CH (1) CH632164A5 (nl)
DE (1) DE2807202C2 (nl)
DK (1) DK78378A (nl)
FR (1) FR2380782A1 (nl)
GB (1) GB1546027A (nl)
IE (1) IE46409B1 (nl)
IL (1) IL54063A0 (nl)
IT (1) IT1092337B (nl)
LU (1) LU79090A1 (nl)
NL (1) NL189281C (nl)
NZ (1) NZ186489A (nl)
PH (1) PH13858A (nl)
SE (1) SE444647B (nl)
ZA (1) ZA78890B (nl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2732587A1 (de) * 1976-09-22 1978-03-23 Bach Jean Francois Polypeptid mit thymischer wirksamkeit
US4148788A (en) * 1978-01-23 1979-04-10 Hoffmann-La Roche Inc. Synthesis of thymosin α1
US4239498A (en) * 1978-11-27 1980-12-16 Rule Allyn H Method of preparing thymic factors and composition
US4264571A (en) * 1979-01-22 1981-04-28 George Washington University Radioimmunoassay of thymosin α1
WO1982000407A1 (en) * 1980-08-08 1982-02-18 Sykes A Improved racking
US4389343A (en) * 1981-12-24 1983-06-21 Hoffmann-La Roche Inc. Immunopotentiating peptides from thymus
US4388234A (en) * 1981-12-28 1983-06-14 Hoffmann-La Roche Inc. Peptide isolation
US4614731A (en) * 1983-09-15 1986-09-30 Hoffmann-La Roche Inc. Peptide having immunopotentiating activity similar to thymosin alpha1
US4659694A (en) * 1983-10-27 1987-04-21 Hoffmann-La Roche Inc. Prothymosin alpha
US4814434A (en) * 1984-02-03 1989-03-21 Ventres Laboratories, Inc. Inducer of T-suppressor cells
DE3633651A1 (de) * 1986-10-03 1988-04-14 Alfred Dr Dick Verwendung von fraktionen aus thymus- und milzextrakten zur behandlung der psoriasis
US5273963A (en) * 1991-03-29 1993-12-28 The George Washington University Compositions and methods for treating small cell and nonsmall cell lung cancers
JP4404866B2 (ja) 2006-03-03 2010-01-27 ゼライス株式会社 エンドトキシン含有量を低減したゼラチンの製造方法および低エンドトキシンゼラチン

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4002602A (en) * 1974-03-11 1977-01-11 Gideon Goldstein Ubiquitous immunopoietic polypeptide (UBIP) and methods
US4010148A (en) * 1975-05-12 1977-03-01 Board Of Regents Of The University Of Texas System Purified thymosin and process
US4002740A (en) * 1975-08-21 1977-01-11 Gideon Goldstein Tridecapeptide compositions and methods

Also Published As

Publication number Publication date
ZA78890B (en) 1979-01-31
IT1092337B (it) 1985-07-06
FR2380782A1 (fr) 1978-09-15
DK78378A (da) 1978-08-23
IL54063A0 (en) 1978-04-30
IE780335L (en) 1978-08-22
AU516946B2 (en) 1981-07-02
NL189281B (nl) 1992-10-01
US4082737A (en) 1978-04-04
AT363177B (de) 1981-07-10
IE46409B1 (en) 1983-06-01
ATA124578A (de) 1980-12-15
FR2380782B1 (nl) 1980-01-18
DE2807202C2 (de) 1987-04-02
CH632164A5 (de) 1982-09-30
JPS53104719A (en) 1978-09-12
CA1099633A (en) 1981-04-21
IT7819791A0 (it) 1978-01-30
LU79090A1 (fr) 1979-05-25
NL7801422A (nl) 1978-08-24
DE2807202A1 (de) 1978-08-24
SE444647B (sv) 1986-04-28
SE7802014L (sv) 1978-08-23
GB1546027A (en) 1979-05-16
BE864139A (fr) 1978-08-21
NZ186489A (en) 1981-01-23
JPS618806B2 (nl) 1986-03-18
AU3334378A (en) 1979-08-23
PH13858A (en) 1980-10-22

Similar Documents

Publication Publication Date Title
NL189281C (nl) Werkwijze voor het bereiden van eiwitmateriaal met hormonale activiteit uit de thymus, en preparaat dat dergelijk eiwitmateriaal bevat.
IT8026950A0 (it) Particelle di sostanze solubili in lipoidi e composizioni biologicamente attive che le contengono.
ATE199096T1 (de) Il-11 aus säugetier
NL181712B (nl) Dialysesysteem in het bijzonder middelen voor het steriliseren daarvan.
IT8721005A0 (it) Metodo per la preservazione difogli trapiantabili di epitelio coltivato in vitro vitale.
NL7706532A (nl) Werkwijze voor het bereiden van esters met anti- bacteriele werking, alsmede zodanige esters be- vattende farmaceutische preparaten.
BR9306345A (pt) Métodos para suprimir a habilidade de células-t de um mamífero de proliferar e para suprimir resposta imune composições para uso na supressão da capacidade de células-t de proliferarem e na supressão de resposta imune
EP0147146A3 (en) Enhancement of transdermal drug delivery
IT8022237A0 (it) Sistema di trasporto per articoli aforma di barretta, particolarmente sigarette.
IT8423517A0 (it) Composizione farmaceutica per combattere infezioni virali, eprocedimento di uso per le infezioni virali.
NL164275C (nl) Werkwijze voor de bereiding van analgetisch werkzame hexahydro-1h-azepinederivaten, werkwijze ter bereiding van farmaceutische preparaten op basis van hexahydro- -1h-azepinederivaten en de onder toepassing daarvan verkregen gevormde farmaceutische preparaten.
NL149812B (nl) Werkwijze ter bereiding van farmaceutische preparaten, alsmede werkwijze ter bereiding van kristallijn cytidine-5'-difosfaat-choline-monohydraat.
NL7514230A (nl) Verpakking uit vezelmassa of ander meegevend materiaal, voor breekbare voorwerpen, in het bijzonder eieren.
NL7600276A (nl) Systeem voor tomografisch onderzoek met behulp van gammastralen.
IT1206323B (it) Preparazioni farmaceutiche con azione citostatica.
NL158783B (nl) Werkwijze voor het bereiden van farmaceutische preparaten met antifibrinolytische werking, door toepassing daarvan verkregen gevormde voortbrengselen, alsmede werkwijze ter bereiding van antifibrinolytisch werkzame aminozuren.
NL7412261A (nl) Werkwijze voor het bereiden van n'-(aminoacyl- aminofenyl)aceetamidinen, alsmede de toepassing daarvan als farmaceutische preparaten.
NL7810682A (nl) Plaat uit een stuk van elastisch materiaal, in het bijzonder voor het absorberen van trillingen.
IT8022188A0 (it) Derivati nicotinici di glucosamina, procedimento per la preparazione e relative composizioni farmaceutiche.
FA et al. Influence of combined effects of bleomycin and X-rays on the growth rate of eat and hela cells
Mergenhagen et al. Transformation of mouse B-lymphocytes by the lipid component of endotoxin
FR1147724A (fr) Système élastique pour coussins, dossiers de sièges ou objets analogues
ES244762Y (es) Estructura perfeccionada para respaldos de asientos, o rema-tes de muebles
ES496823A0 (es) Sistema transportador para articulos con forma de barrita,enparticular cigarrillos
IT7822999V0 (it) Staffa di collegamento e supporto, in particolare per mobili.

Legal Events

Date Code Title Description
BB A search report has been drawn up
A85 Still pending on 85-01-01
BC A request for examination has been filed
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: HOFFMANN-LA ROCHE AG. F. -

V1 Lapsed because of non-payment of the annual fee

Effective date: 19960901